Nanoscale Science, Engineering, and Technology Subcommittee; Committee on Technology, National Science and Technology Council; Meeting, 53220 [2014-21201]

Download as PDF 53220 Federal Register / Vol. 79, No. 173 / Monday, September 8, 2014 / Notices Established 2015 quotas (g) Basic class Noroxymorphone (for sale) .......................................................................................................................................................... Opium (powder) ........................................................................................................................................................................... Opium (tincture) ........................................................................................................................................................................... Oripavine ...................................................................................................................................................................................... Oxycodone (for conversion) ........................................................................................................................................................ Oxycodone (for sale) ................................................................................................................................................................... Oxymorphone (for conversion) .................................................................................................................................................... Oxymorphone (for sale) ............................................................................................................................................................... Pentobarbital ................................................................................................................................................................................ Phenazocine ................................................................................................................................................................................ Phencyclidine ............................................................................................................................................................................... Phenmetrazine ............................................................................................................................................................................. Phenylacetone ............................................................................................................................................................................. Racemethorphan ......................................................................................................................................................................... Remifentanil ................................................................................................................................................................................. Secobarbital ................................................................................................................................................................................. Sufentanil ..................................................................................................................................................................................... Tapentadol ................................................................................................................................................................................... Thebaine ...................................................................................................................................................................................... 1,475,000 112,500 687,500 35,000,000 8,350,000 137,500,000 29,000,000 7,750,000 35,000,000 6 19 3 9,375,000 3 3,750 215,003 6,255 12,500,000 125,000,000 List I Chemicals Ephedrine (for conversion) .......................................................................................................................................................... Ephedrine (for sale) ..................................................................................................................................................................... Phenylpropanolamine (for conversion) ........................................................................................................................................ Phenylpropanolamine (for sale) ................................................................................................................................................... Pseudoephedrine (for conversion) .............................................................................................................................................. Pseudoephedrine (for sale) ......................................................................................................................................................... The Deputy Administrator also establishes aggregate production quotas for all other schedule I and II controlled substances included in 21 CFR 1308.11 and 1308.12 at zero. In accordance with 21 CFR 1303.13 and 21 CFR 1315.13, upon consideration of the relevant factors, the Deputy Administrator may adjust the 2015 aggregate production quotas and assessment of annual needs as needed. Dated: September 2, 2014. Thomas M. Harrigan, Deputy Administrator. [FR Doc. 2014–21280 Filed 9–5–14; 8:45 am] BILLING CODE 4410–09–P OFFICE OF SCIENCE AND TECHNOLOGY POLICY National Nanotechnology Coordination Office Nanoscale Science, Engineering, and Technology Subcommittee; Committee on Technology, National Science and Technology Council; Meeting rmajette on DSK2TPTVN1PROD with NOTICES ACTION: Notice of public meeting. The National Nanotechnology Coordination Office (NNCO), on behalf of the Nanoscale Science, Engineering, and Technology (NSET) Subcommittee of the Committee on Technology, National Science and Technology Council (NSTC), will hold a technical SUMMARY: VerDate Mar<15>2010 15:14 Sep 05, 2014 Jkt 232001 interchange meeting entitled ‘‘Realizing the Promise of Carbon Nanotubes— Challenges, Opportunities and the Pathway to Commercialization’’ on September 15, 2014. The meeting will be sponsored by the National Nanotechnology Initiative (NNI) and cosponsored by the National Aeronautics and Space Administration (NASA). The objectives of this meeting are to identify, discuss, and report the technical barriers preventing the production of carbon nanotube-based materials with electrical and mechanical properties approaching theoretical values, and to explore ways to overcome these barriers. Obstacles preventing the full exploitation of the multifunctional nature of carbon nanotube materials will also be discussed. This one-day meeting will assemble some of the Nation’s leading experts in carbon nanotube research and development, as well as executives and experts from the Federal government, academia, and private sector. The technical interchange meeting will be held Monday, September 15, 2014 from 8:00 a.m. until 5:15 p.m. ADDRESSES: The technical interchange meeting will be held at the National Aeronautics and Space Administration (NASA) Headquarters, 300 E Street Southwest, Washington, DC 20546. FOR FURTHER INFORMATION, CONTACT: Dr. Tarek Fadel, 703–292–7926, tfadel@ DATES: PO 00000 Frm 00059 Fmt 4703 Sfmt 9990 1,000,000 4,000,000 44,800,000 8,500,000 7,000 224,500,000 nnco.nano.gov, NNCO. Additional information is posted at: http:// nano.gov/2014CNTTechInterchange. Registration: Registration opens on September 8, 2014. Due to space limitations, pre-registration for the technical interchange meeting is required. Written notices of participation by email should be sent to dpetreski@nnco.nano.gov or mailed to Diana Petreski, 4201 Wilson Blvd., Stafford II, Suite 405, Arlington, VA 22230. Please provide your full name, title, affiliation and email or mailing address when registering. Registration is on a first-come, first-served basis until capacity is reached. Written or electronic comments should be submitted by email to dpetreski@ nnco.nano.gov until close of business September 10, 2014. Meeting Accommodations: Individuals requiring special accommodation to access this meeting should contact Diana Petreski at 703– 292–7922 at least five business days prior to the meeting so that appropriate arrangements can be made. Ted Wackler, Deputy Chief of Staff and Assistant Director. [FR Doc. 2014–21201 Filed 9–5–14; 8:45 am] BILLING CODE P E:\FR\FM\08SEN1.SGM 08SEN1

Agencies

[Federal Register Volume 79, Number 173 (Monday, September 8, 2014)]
[Notices]
[Page 53220]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21201]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF SCIENCE AND TECHNOLOGY POLICY

National Nanotechnology Coordination Office


Nanoscale Science, Engineering, and Technology Subcommittee; 
Committee on Technology, National Science and Technology Council; 
Meeting

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: The National Nanotechnology Coordination Office (NNCO), on 
behalf of the Nanoscale Science, Engineering, and Technology (NSET) 
Subcommittee of the Committee on Technology, National Science and 
Technology Council (NSTC), will hold a technical interchange meeting 
entitled ``Realizing the Promise of Carbon Nanotubes--Challenges, 
Opportunities and the Pathway to Commercialization'' on September 15, 
2014. The meeting will be sponsored by the National Nanotechnology 
Initiative (NNI) and co-sponsored by the National Aeronautics and Space 
Administration (NASA). The objectives of this meeting are to identify, 
discuss, and report the technical barriers preventing the production of 
carbon nanotube-based materials with electrical and mechanical 
properties approaching theoretical values, and to explore ways to 
overcome these barriers. Obstacles preventing the full exploitation of 
the multifunctional nature of carbon nanotube materials will also be 
discussed. This one-day meeting will assemble some of the Nation's 
leading experts in carbon nanotube research and development, as well as 
executives and experts from the Federal government, academia, and 
private sector.

DATES: The technical interchange meeting will be held Monday, September 
15, 2014 from 8:00 a.m. until 5:15 p.m.

ADDRESSES: The technical interchange meeting will be held at the 
National Aeronautics and Space Administration (NASA) Headquarters, 300 
E Street Southwest, Washington, DC 20546.

FOR FURTHER INFORMATION, CONTACT: Dr. Tarek Fadel, 703-292-7926, 
tfadel@nnco.nano.gov, NNCO. Additional information is posted at: http://nano.gov/2014CNTTechInterchange.
    Registration: Registration opens on September 8, 2014. Due to space 
limitations, pre-registration for the technical interchange meeting is 
required. Written notices of participation by email should be sent to 
dpetreski@nnco.nano.gov or mailed to Diana Petreski, 4201 Wilson Blvd., 
Stafford II, Suite 405, Arlington, VA 22230. Please provide your full 
name, title, affiliation and email or mailing address when registering. 
Registration is on a first-come, first-served basis until capacity is 
reached. Written or electronic comments should be submitted by email to 
dpetreski@nnco.nano.gov until close of business September 10, 2014.
    Meeting Accommodations: Individuals requiring special accommodation 
to access this meeting should contact Diana Petreski at 703-292-7922 at 
least five business days prior to the meeting so that appropriate 
arrangements can be made.

Ted Wackler,
Deputy Chief of Staff and Assistant Director.
[FR Doc. 2014-21201 Filed 9-5-14; 8:45 am]
BILLING CODE P